Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resistant Hypertension: Novel Insights
Guillaume Lamirault, Mathieu Artifoni, Mélanie Daniel, et al.
Current Hypertension Reviews (2019) Vol. 16, Iss. 1, pp. 61-72
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Essential Hypertension and Oxidative Stress: Novel Future Perspectives
Caterina Franco, Edoardo Sciatti, Gaia Favero, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14489-14489
Open Access | Times Cited: 83
Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect
Linnea Højer Wang, Markus Wehland, Petra M. Wise, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2312-2312
Open Access | Times Cited: 23
Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension
Giuseppe Mancia, Francesco P. Cappuccio, Michel Burnier, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 3, pp. 251-268
Open Access | Times Cited: 22
RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases
Wanwan Zhou, Changhui Wang, Jun Chang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 35
Network pharmacology- and molecular docking-based analyses of the antihypertensive mechanism of Ilex kudingcha
Fei Liao, Muhammad Yousif, Ruya Huang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15
Microneedles and Their Application in Transdermal Delivery of Antihypertensive Drugs—A Review
Ramsha Khalid, Syed Mahmood, Zarif Mohamed Sofian, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2029-2029
Open Access | Times Cited: 14
Advances in the Pathogenesis and Treatment of Resistant Hypertension
Jill Dybiec, Julia Krzemińska, Ewa Radzioch, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12911-12911
Open Access | Times Cited: 13
Hypertensive Heart Failure
Filippos Triposkiadis, Pantelis Sarafidis, Αlexandros Briasoulis, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5090-5090
Open Access | Times Cited: 11
Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial
José C. E. Serrano, Eva Castro-Boqué, Alicia García-Carrasco, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3691-3691
Open Access | Times Cited: 11
Cardiovascular Risk Factors in Middle-Aged Lithuanian Men: A Comparative Study of an Apparently Resistant Hypertension Group
Vaida Šileikienė, V. Dženkevičiūtė, Alma Čypienė, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 435-435
Open Access
Effects of a 6-Week Concurrent Training Program Combining Resistance and Various Modalities of Aerobic Exercise in Obese Women with Prehypertension: A Randomized Controlled Trial
Jie Yu, Eunjoo Lee, Jae-Ho Choi, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 278-278
Open Access
Effect of Metacognitive Strategy-guided Health Management Model in Patients with Hypertension and Hyperlipidemia
Ye Min Kuang, Ling Chen, Liu-Rong Xie
Angiology (2025)
Closed Access
Interdisciplinary telehealth team positively impacts difficult to control hypertension in chronic kidney disease
John M. Dopp, Austin Lange, Laura Maursetter
Kidney360 (2023)
Open Access | Times Cited: 9
Sexual Dimorphic Interplays Between Gut Microbiota and Antihypertensive Drugs
Pritam Bardhan, Tao Yang
Current Hypertension Reports (2023) Vol. 25, Iss. 8, pp. 163-172
Open Access | Times Cited: 9
Efficacy and Safety of Radiofrequency-Based Renal Denervation on Resistant Hypertensive Patients: A Systematic Review and Meta-analysis
Luis Eduardo Rodrigues Sobreira, Fernando Baía Bezerra, Vitor Kendi Tsuchiya Sano, et al.
High Blood Pressure & Cardiovascular Prevention (2024) Vol. 31, Iss. 4, pp. 329-340
Closed Access | Times Cited: 3
miPEP31 alleviates Ang II-induced hypertension in mice by occupying Cebpα binding sites in the pri-miR-31 promoter
Xiangxiao Li, Hong Zhou, Pengfei Lu, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Secondary Hypertension: Novel Insights
Κωνσταντίνος Τζιόμαλος
Current Hypertension Reviews (2019) Vol. 16, Iss. 1, pp. 11-11
Closed Access | Times Cited: 23
Clinical characteristics and outcomes of Chinese patients with coronary heart disease and resistant hypertension
Binbin Zhu, Yahui Liu, Weicen Zhou, et al.
Journal of Clinical Hypertension (2023) Vol. 25, Iss. 4, pp. 350-359
Open Access | Times Cited: 7
Aprocitentan, a dual endothelin-1 (ET-1) antagonist for treating resistant hypertension: Mechanism of action and therapeutic potential
Jing-Jing Xu, Xiaohua Jiang, Suowen Xu
Drug Discovery Today (2023) Vol. 28, Iss. 11, pp. 103788-103788
Closed Access | Times Cited: 6
The effect of combining therapeutic drug monitoring of antihypertensive drugs with personalised feedback on adherence and resistant hypertension: the (RHYME-RCT) trial protocol of a multi-centre randomised controlled trial
Laura Peeters, M. H. W. Kappers, Eric Boersma, et al.
BMC Cardiovascular Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
A Preliminary Study on the Value of Intestinal Flora in Predicting Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Refractory Hypertension
Jie Jiao, Yeping Zhang, Pengda Han, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 9
The effect of CYP3A4 genetic polymorphism and drug interaction on the metabolism of istradefylline
Xiaoqin Hu, Jinhuan Ni, Nanyong Gao, et al.
Chemico-Biological Interactions (2022) Vol. 366, pp. 110123-110123
Closed Access | Times Cited: 7
Association between hypertensive disorders during pregnancy and elevated blood pressure in offspring: A systematic review and meta‐analysis
Huan Yu, Wei Li, Zhengxia Mao, et al.
Journal of Clinical Hypertension (2022) Vol. 24, Iss. 11, pp. 1397-1404
Open Access | Times Cited: 7
Candesartan upregulates angiotensin‐converting enzyme 2 in kidneys of male animals by decreased ubiquitination
Ping Wang, Zhiyun Ren, Weiwan Wang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 6
Closed Access | Times Cited: 1
Recent developments in the management of resistant hypertension: focus on endothelin receptor antagonists
Sayeh Heidari Nejad, Omar Azzam, Markus P. Schlaich
Future Cardiology (2024) Vol. 20, Iss. 9, pp. 435-445
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top